Skip to main content Skip to navigation

Research Exchange

Combining repetitive element-specific T cells with epigenetic therapy to treat ovarian cancer

Type

grant

Grant Number

F31 CA271788

A global leader in the fight against gynecologic cancer

LIVING LAB

Join the Living Lab Our Team Governance & Ethics Social Media Toolkit

DISCOVERY LAB

Discovery Lab How It Works Upcoming Webinars Contribute Data

ABOUT

About OCRA Get Involved Make a Donation Contact Us

© 2025 Ovarian Cancer Research Alliance, Inc.

Privacy Terms Accessibility

Combining repetitive element-specific T cells with epigenetic therapy to treat ovarian cancer